|Application:||Gene expression microarray analysis|
|Number of samples:||270|
|Release date:||Mar 1 2012|
|Last update date:||Oct 29 2018|
|Diseases:||Neoplasms, Ovarian Neoplasms|
|Dataset link||Immune-activation as a therapeutic direction for patients with high-risk ovarian cancer based on gene expression signature (1)|
Two hundred sixty patients who were diagnosed as advanced-stage high-grade serous ovarian cancer were analyzed in this study. Microaray data from 10 patients who were diagnosed as advanced-stage high-grade serous ovarian cancer were analyzed to investigate coefficient of correlation in each probes between Agilent Whole Human Genome Oligo Microarray and Affymetrix HG-U133Plus2.0.